196 related articles for article (PubMed ID: 1722348)
21. Improved detection of antibodies to hepatitis C virus by the second-generation assay in patients with chronic non-A, non-B liver disease.
Hayashi J; Nakashima K; Kishihara Y; Ohmiya M; Yoshimura E; Hirata M; Kashiwagi S
J Infect; 1993 May; 26(3):287-94. PubMed ID: 7685043
[TBL] [Abstract][Full Text] [Related]
22. Diagnosis of hepatitis C virus (HCV) infection using an immunodominant chimeric polyprotein to capture circulating antibodies: reevaluation of the role of HCV in liver disease.
Chien DY; Choo QL; Tabrizi A; Kuo C; McFarland J; Berger K; Lee C; Shuster JR; Nguyen T; Moyer DL
Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10011-5. PubMed ID: 1279666
[TBL] [Abstract][Full Text] [Related]
23. IgM antibody to a hepatitis C virus core peptide (CP14) for monitoring activity of liver disease in patients with acute or chronic hepatitis C.
Nagayama R; Miyake K; Tsuda F; Okamoto H
J Med Virol; 1994 Mar; 42(3):311-7. PubMed ID: 7516423
[TBL] [Abstract][Full Text] [Related]
24. The clinical significance of reactivity to individual epitopes of the hepatitis C viral genome.
Yatsuhashi H; Inokuchi K; Inoue O; Matsumura N; Koga M; Kosakai Y; Yano M
Gastroenterol Jpn; 1993 May; 28 Suppl 5():6-11. PubMed ID: 7689509
[TBL] [Abstract][Full Text] [Related]
25. [Serodiagnosis of hepatitis C by a recombinant hepatitis C virus protein].
Hayashi N; Yuki N; Kasahara A; Fusamoto H; Kamada T
Nihon Rinsho; 1993 Feb; 51(2):329-33. PubMed ID: 7681883
[TBL] [Abstract][Full Text] [Related]
26. Relationship between serum HCV markers and response to interferon therapy in chronic hepatitis C. Evaluation of HCV genotypes during and after long-term follow-up.
Diodati G; Bonetti P; Tagger A; Casarin C; Noventa F; Ribero M; Fasola M; Ruol A; Realdi G
Dig Dis Sci; 1994 Nov; 39(11):2497-502. PubMed ID: 7525169
[TBL] [Abstract][Full Text] [Related]
27. Demonstration of viraemia patterns in haemophiliacs treated with hepatitis-C-virus-contaminated factor VIII concentrates.
Garson JA; Tuke PW; Makris M; Briggs M; Machin SJ; Preston FE; Tedder RS
Lancet; 1990 Oct; 336(8722):1022-5. PubMed ID: 1977017
[TBL] [Abstract][Full Text] [Related]
28. Early antihepatitis C virus response with second-generation C200/C22 ELISA.
van der Poel CL; Bresters D; Reesink HW; Plaisier AA; Schaasberg W; Leentvaar-Kuypers A; Choo QL; Quan S; Polito A; Houghton M
Vox Sang; 1992; 62(4):208-12. PubMed ID: 1322611
[TBL] [Abstract][Full Text] [Related]
29. Seroconversion to hepatitis C virus antibodies in patients with acute posttransfusion non-A, non-B hepatitis in Sweden.
Mattsson L; Grillner L; von Sydow M; Bergdahl S; Weiland O
Infection; 1991; 19(5):309-12. PubMed ID: 1666063
[TBL] [Abstract][Full Text] [Related]
30. Hepatitis C virus detection is facilitated by the combined use of c100 protein and GOR epitope.
Hayashi J; Nakashima K; Hirata M; Noguchi A; Akazawa K; Maeda Y; Kashiwagi S
Gastroenterol Jpn; 1992 Oct; 27(5):632-7. PubMed ID: 1385249
[TBL] [Abstract][Full Text] [Related]
31. Antibodies to hepatitis C virus and hepatitis C virus infection.
Yuki N; Hayashi N; Kasahara A; Hagiwara H; Fusamoto H; Kamada T
Gastroenterol Jpn; 1993 May; 28 Suppl 5():76-9. PubMed ID: 7689512
[TBL] [Abstract][Full Text] [Related]
32. Characterization of the antibody reactivity to synthetic peptides from different parts of the hepatitis C virus genome.
Pujol FH; Khudyakov YE; Devesa M; León G; Blitz-Dorfman L; Monsalve F; Lambert SB; Kalinina TY; Liprandi F; Fields HA
Viral Immunol; 1996; 9(2):89-96. PubMed ID: 8822625
[TBL] [Abstract][Full Text] [Related]
33. [Liatek HCV: the six-antigen test for confirmation of the presence of anti-HCV antibodies].
Juszczyk J; Flieger J; Migdalski P; Skalisz H
Przegl Epidemiol; 1992; 46(1-2):11-7. PubMed ID: 1282266
[TBL] [Abstract][Full Text] [Related]
34. IgM antibody response in acute hepatitis C viral infection.
Clemens JM; Taskar S; Chau K; Vallari D; Shih JW; Alter HJ; Schleicher JB; Mimms LT
Blood; 1992 Jan; 79(1):169-72. PubMed ID: 1309424
[TBL] [Abstract][Full Text] [Related]
35. Relation between reactivity to the NS-4 region peptides of hepatitis C virus (HCV) and clinical features among patients infected with HCV genotype 1b.
Sakugawa H; Nakasone H; Nakayoshi T; Kawakami Y; Kinjo F; Saito A; Nakayoshi T; Yamashiro A
Microbiol Immunol; 1998; 42(4):299-303. PubMed ID: 9623917
[TBL] [Abstract][Full Text] [Related]
36. Patterns of serological markers in transfusion-transmitted hepatitis C virus infection using second-generation HCV assays.
Lelie PN; Cuypers HT; Reesink HW; van der Poel CL; Winkel I; Bakker E; van Exel-Oehlers PJ; Vallari D; Allain JP; Mimms L
J Med Virol; 1992 Jul; 37(3):203-9. PubMed ID: 1331309
[TBL] [Abstract][Full Text] [Related]
37. Improved detection of anti-HCV in post-transfusion hepatitis by a third-generation ELISA.
Barrera JM; Francis B; Ercilla G; Nelles M; Achord D; Darner J; Lee SR
Vox Sang; 1995; 68(1):15-8. PubMed ID: 7536987
[TBL] [Abstract][Full Text] [Related]
38. Clinical significance of antibodies to nonstructural and core proteins of hepatitis C virus in posttransfusion hepatitis patients during long-term follow-up.
Tanaka E; Kiyosawa K; Nakatsuji Y; Inoue Y; Miyamura T; Chiba J; Furuta S
J Med Virol; 1993 Apr; 39(4):318-24. PubMed ID: 7684063
[TBL] [Abstract][Full Text] [Related]
39. Serum hepatitis C virus sequences in posttransfusion non-A, non-B hepatitis.
Shibata M; Morishima T; Kudo T; Maki T; Maki S; Nagai Y
Blood; 1991 Mar; 77(6):1157-60. PubMed ID: 1705830
[TBL] [Abstract][Full Text] [Related]
40. Detection of antibodies to hepatitis C virus (anti-HCV) in patients with various liver diseases, by an ELISA (KCL-163) test consisting of synthetic peptides corresponding to an HCV genome.
Kawano S; Fujiyama S; Sato S; Yoshida K; Shibata J; Murata H; Kawahara T; Mizuno K; Nonaka S; Sato T
Gastroenterol Jpn; 1991 Jul; 26 Suppl 3():218-20. PubMed ID: 1653163
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
